Neurofeedback provides information about measured brain activity while a person practices a task. A service may use sounds, a game or a visual display to reinforce a selected signal pattern. The proposed aim is to help the person learn a response that translates into a useful change outside the session.
The important phrase is translates into a useful change. A better training score or a different EEG pattern is not automatically the same as improved attention, sleep or well-being. Before committing to treatment, ask what the equipment measures, how the target was chosen and what evidence supports the intended clinical outcome.
What is neurofeedback?
Many neurofeedback services use an electroencephalogram, or EEG, to record electrical activity through sensors on the scalp. Research also includes other technologies, such as functional MRI feedback. These methods differ and should not be treated as a single uniform treatment with one success rate.
The NHS describes EEG as a recording test, commonly used in the assessment of conditions such as epilepsy. Neurofeedback uses a recording within a training procedure, which is a different purpose. A medical EEG investigation and a commercial training session should not be confused merely because both use sensors. NHS: what an EEG records.
What happens in an EEG neurofeedback session?
A practitioner may place sensors on the scalp and explain a task in which feedback changes according to a selected feature of the recording. The procedure should be described before it begins, including preparation, session length and what participation involves. You should understand whether the equipment only records or whether another intervention is also being used.
Ask how movement, blinking or muscle activity is handled in the recording. An appealing display does not explain the quality of the underlying signal. The provider should be able to describe, at an appropriate level, how the measurement is processed and why the training target is relevant.
The session should also include a way to report discomfort and discuss your experience. A person should not feel required to interpret every change in a device score as improvement or blame themselves when the target is difficult to achieve.
Can a brain map diagnose ADHD or trauma?
A color-coded map should not be presented as a standalone diagnosis of ADHD, PTSD or another mental health condition. Clinical assessment requires more than a device output. NICE describes ADHD diagnosis as a specialist process involving clinical and developmental history, symptoms across settings and functional impact. NICE: ADHD assessment and diagnosis.
Ask exactly what a report establishes and what it does not. A difference from a reference database is not automatically a disease, an explanation of every symptom or proof that a training package is necessary. Relevant uncertainty should be explained before you are asked to purchase treatment.
What does the ADHD research show?
A double-blind trial published in June 2026 studied a personalized upper-alpha EEG protocol in children with ADHD. Training changed the targeted signals and improved selected motor-speed measures, but did not outperform sham feedback on the primary parent-rated ADHD symptom outcome. This is a clear example of why learning a signal and improving a clinical condition must be evaluated separately. Read the 2026 trial.
An adult ADHD trial compared neurofeedback, a sham-feedback condition and a structured group psychotherapy. Symptoms improved across groups, but neurofeedback did not show a specific advantage over the comparison conditions. The study concerned a particular protocol and population; it does not settle every possible use, but it challenges broad claims of established superiority. Read the adult controlled trial.
These findings do not mean that a person’s reported improvement is unreal. They mean that improvement can reflect several aspects of participation and that a specific treatment effect needs a suitable comparison. Ask whether the evidence concerns the same protocol, age group and outcome as the service being offered.
Why sham-controlled studies matter
Repeated appointments, focused practice, encouragement and expectations can all affect how people feel or perform. A sham comparison tries to separate those influences from the feedback target itself. Without that comparison, a before-and-after change cannot establish which part of the program made the difference.
Study design also affects interpretation. Who rated the symptoms, did they know which treatment was received, and was the main outcome chosen in advance? An improvement on one of many secondary tests should not be advertised as though the primary clinical question was answered positively.
A provider should be able to discuss research limitations alongside favorable findings. Testimonials and screenshots of changed signals may be interesting, but they cannot replace controlled evidence about sustained benefits, adverse effects or the best use of the person’s time and resources.
Neurofeedback is not the same as brain stimulation
EEG recording-based feedback is different from treatments that apply magnetic or electrical stimulation. Transcranial magnetic stimulation has its own procedures, indications and evidence. The shared language of brain-based treatment does not make the interventions interchangeable.
Biofeedback is a broader category that can involve signals such as muscle tension or breathing-related measures. Ask which signal is being used and what condition-specific evidence supports it. A general claim that feedback helps self-regulation is not enough to establish a treatment for every diagnosis.
A practical example of evaluating a program
Imagine being offered neurofeedback because concentration at work has become difficult. Before interpreting a training score, a clinician should consider sleep, mood, medication, workload and whether ADHD or another condition needs assessment. Different explanations can lead to different care.
A useful goal might be completing important tasks with fewer disruptions. You and the clinician could agree how that will be measured outside the device, what else is changing and when progress will be reviewed. If only the game score improves, the plan needs an honest discussion rather than an automatic recommendation to buy more sessions.
What established care should remain available?
The ADHD treatment guide and adult ADHD treatment guide describe assessment-led options. These can include environmental adjustments, psychological support and medication where appropriate. Neurofeedback should not be used to delay relevant assessment or require abandoning care that is helping.
Medication decisions should be made with the prescriber. A changed EEG display does not independently establish that a medicine is unnecessary. The medication-management guide explains the importance of reviewing benefits, side effects and everyday functioning together.
Safety, discomfort and professional responsibility
Ask how the service records adverse experiences and what happens if sleep, mood or other symptoms worsen. Non-invasive does not mean that a program needs no monitoring. New or concerning symptoms should be assessed rather than automatically explained as the brain adapting or healing.
Check the practitioner’s underlying clinical qualifications, relevant training, supervision and ability to recognize needs outside their scope. Equipment ownership or a technique certificate is not the same as competence to diagnose and treat complex mental health or neurological conditions.
Costs, data privacy and home systems
Request the full expected cost, including assessment, mapping, appointments, device rental and review. Ask what evidence justifies the proposed number of sessions and what criteria would lead to stopping. A large prepaid package should not replace a clear plan for evaluating benefit.
For home systems, clarify who reviews recordings, how support is provided and where data are stored. Ask whether the company can use recordings for other purposes and what happens when the subscription ends. A consumer device should not be assumed equivalent to a clinically supervised research program.
Frequently asked questions
Does EEG neurofeedback send electricity into the brain?
EEG recording itself measures activity through scalp sensors. Other interventions may apply stimulation, so ask exactly what the service uses. Recording, neurofeedback and electrical or magnetic stimulation are different procedures with different considerations.
Is neurofeedback a proven cure for ADHD?
No universal cure claim is justified. Controlled trials of particular protocols have not always shown an advantage over sham feedback, including recent research. Discuss the actual evidence and alternatives rather than accepting a promise of permanent correction or guaranteed medication-free recovery.
Can a brain map tell me why I feel anxious?
A map is not a complete explanation of anxiety or a standalone psychiatric diagnosis. Symptoms need a clinical assessment that considers history, health and circumstances. Ask what conclusions are supported by the test and whether additional assessment is necessary.
What if my training score improves but daily life does not?
That distinction should be part of the review. A signal change is not sufficient evidence that the clinical goal has been met. Discuss whether the target is relevant, whether more useful support is available and what would justify continuing the program.
How many sessions are needed?
Protocols vary, and a fixed number cannot guarantee benefit. Ask which study or clinical rationale supports the proposed schedule and when outcomes will be reviewed. A recommendation for more sessions should be based on evidence and your experience, not only the provider’s standard package.
Should I stop medication before training?
Do not make that decision independently. Discuss any proposed change with the prescribing clinician, including why it is suggested and the risks involved. A service should not require abandoning necessary treatment on the basis of a general claim about retraining the brain.
Is a home device the same as clinical neurofeedback?
Not necessarily. Hardware, signal processing, supervision and the protocol can differ. Evidence from a supervised clinical study cannot automatically be transferred to a consumer product. Ask what support and condition-specific evidence exist for the exact system.
Discussing the next step
An initial assessment can clarify the symptoms and goals before a device-based program is considered. The resulting plan should prioritize meaningful outcomes, appropriate care and a clear explanation of uncertainty.
Sources and further reading
- NHS: EEG recording and clinical uses.
- NICE: ADHD assessment and management.
- 2026 sham-controlled trial of personalised neurofeedback in children.
- Adult ADHD trial comparing neurofeedback, sham feedback and group psychotherapy.
Related conditions and concerns
These links explain the wider care context. They are not a recommendation that this approach is suitable for everyone with the condition. Use the condition treatment guide to understand alternatives and the role of clinical assessment.